RaySearch Laboratories AB (publ) RAY B.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker RAY B.ST. It has been listed since 29 May 1990. In the fiscal year to 31 December 2025, it reported revenue of SEK 1.34bn and net income of SEK 227.8m. At that date it held total assets of SEK 1.99bn and shareholders' equity of SEK 985.3m.

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Hans WigzellIndependent Chairman of the BoardSEK 840,000
• Mr. Johan LoefChief Executive Officer, Founder, Director, since 2000SEK 13.6m
• Mr. Bjoern HardemarkDeputy Chief Executive Officer, since 2023SEK 4.3m
• Ms. Nina GronbergChief Financial Officer
• Mr. Kjell ErikssonChief Science Officer
• Ms. Petra JanssonGeneral Counsel
• Mr. Lars JordebyDirector of Sales and Marketing, Asia-Pacific and Middle East
• Mr. Peter KemlinDirector of Sales and Marketing
• Ms. Tove AlteborGlobal Human Resource Manager
• Mr. Niclas BorglundDirector of Service, since 2010
• Mr. Henrik FribergerDirector of Development, since 2013
• Mr. David HedforsDirector of Quality and Regulatory Affairs

Overall

40

Environment

25

Social

76

Governance

20

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.